Kumagai H
Research Center, Asahi Glass Co., Ltd., Yokohama, Japan.
Gan To Kagaku Ryoho. 1995 Apr;22(5):585-91.
Metastasis is often a terminal stage of cancer when tumor fragments lodge and grow in different parts of the body. There is currently no way to prevent metastasis, and there are few effective treatments. We believe that it is very important to develop an anti-tumor metastatic drug. Recent studies on the mechanism of tumor metastasis reveal that this multi-step process requires complex interaction between the tumor cells and their environment. In vitro experiments and animal cancer model studies have shown that the inhibitors of invasion (including adhesion, proteolysis, and migration) and neovascularization may suppress tumor metastasis. The author show a the mechanism of tumor metastasis, an in vitro screening method, and the recent progress of the development of various candidate anti-tumor metastatic drugs, including invasion inhibiting factor-2. Finally, the importance of the development of an anti-tumor metastatic drug in Japan is underscored.
转移通常是癌症的终末期,此时肿瘤碎片在身体不同部位着床并生长。目前尚无预防转移的方法,且有效治疗手段也很少。我们认为开发一种抗肿瘤转移药物非常重要。最近对肿瘤转移机制的研究表明,这个多步骤过程需要肿瘤细胞与其环境之间复杂的相互作用。体外实验和动物癌症模型研究表明,侵袭(包括黏附、蛋白水解和迁移)和新血管生成的抑制剂可能会抑制肿瘤转移。作者展示了肿瘤转移的机制、一种体外筛选方法以及包括侵袭抑制因子-2在内的各种候选抗肿瘤转移药物开发的最新进展。最后,强调了在日本开发抗肿瘤转移药物的重要性。